Cited by 173Antibiotic Use and ResistanceSurgical site infection preventionAbdominal Surgery and Complications

Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: The DURAPOP randomised clinical trial.

Open access
For the DURAPOP Trial Group, Montravers, Philippe, Tubach, Florence, Lescot, Thomas, Veber, Benoit, Esposito-Farèse, Marina, Seguin, Philippe, Paugam, Catherine +10 more·2018·Intensive Care Medicine

Abstract

Purpose Shortening the duration of antibiotic therapy (ABT) is a key measure in antimicrobial stewardship. The optimal duration of ABT for treatment of postoperative intra-abdominal infections (PIAI) in critically ill patients is unknown.Methods A multicentre prospective randomised trial conducted in 21 French intensive care units (ICU) between May 2011 and February 2015 compared the efficacy and safety of 8-day versus 15-day antibiotic therapy in critically ill patients with PIAI. Among 410 eligible patients (adequate source control and ABT on day 0), 249 patients were randomly assigned on day 8 to either stop ABT immediately (n = 126) or to continue ABT until day 15 (n = 123). The primary endpoint was the number of antibiotic-free days between randomisation (day 8) and day 28. Secondary outcomes were death, ICU and hospital length of stay, emergence of multidrug-resistant (MDR) bacteria and reoperation rate, with 45-day follow-up.Results Patients treated for 8 days had a higher median number of antibiotic-free days than those treated for 15 days (15 [6-20] vs 12 [6-13] days, respectively; P < 0.0001) (Wilcoxon rank difference 4.99 days [95% CI 2.99-6.00; P < 0.0001). Equivalence was established in terms of 45-day mortality (rate difference 0.038, 95% CI - 0.013 to 0.061). Treatments did not differ in terms of ICU and hospital length of stay, emergence of MDR bacteria or reoperation rate, while subsequent drainages between day 8 and day 45 were observed following short-course ABT (P = 0.041).Conclusion Short-course antibiotic therapy in critically ill ICU patients with PIAI reduces antibiotic exposure. Continuation of treatment until day 15 is not associated with any clinical benefit. CLINICALTRIALS.Gov identifier NCT01311765.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00134-018-5088-x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In RCTs of intra-abdominal infection, shorter duration antimicrobial therapy showed no difference in outcomes compared with longer duration.

    “Intra-abdominal | Montravers 2018 (305) | 8 days | 15 days | No difference”

    From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as Montravers 2018 (305)

    The Abstract and Discussion report that, in critically ill patients with postoperative intra-abdominal infection, 8 versus 15 days of antibiotics produced equivalent 45-day mortality and no significant difference in several other clinical outcomes. But the unqualified “No difference” overstates the results: subsequent drainages were more frequent after the shorter course, and the finding applies to this specific ICU population rather than intra-abdominal infections generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
For the DURAPOP Trial Group, Montravers, P., Tubach, F., Lescot, T., Veber, B., Esposito-Farèse, M., Seguin, P., Paugam, C., Lepape, A., Meistelman, C., Cousson, J., Tesniere, A., Plantefeve, G., Blasco, G., Asehnoune, K., Jaber, S., Lasocki, S., & Dupont, H.
Affiliations
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Inserm (FR)
  • Centre Hospitalier Régional et Universitaire de Nancy (FR)
  • Centre Hospitalier Universitaire de Besançon (FR)
  • Centre Hospitalier Universitaire de Nantes (FR)
  • Centre Hospitalier Universitaire d'Angers (FR)
Corresponding author
Montravers, Philippe
Venue
Intensive Care Medicine
Published
2018-02-26
Volume
44
Issue
3
Pages
300-310
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W2788905391
Cited by
173
References
33
Citations by year
2026: 9 · 2025: 18 · 2024: 17 · 2023: 24 · 2022: 30 · 2021: 30 · 2020: 17 · 2019: 16 · 2018: 11
FWCI
11.38
Type
journal article
Language
en
Open access
Locations
  • Intensive Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
French Ministery of Health-Programme Hospitalier de Recherche Clinique 2009 (AOM-09024)
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Surgery › Surgical site infection prevention
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Abdominal Surgery and Complications
Keywords
short-course antibiotic therapy, postoperative intra-abdominal infection, critically ill patients, antimicrobial stewardship, antibiotic duration, multidrug-resistant bacteria, reoperation, ICU length of stay, mortality
MeSH terms
Aged, Aged, 80 and over, Anti-Bacterial Agents, Female, France, Humans, Intensive Care Units, Male, Middle Aged, Obesity, Morbid, Prospective Studies, Critical Illness, Intraabdominal Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review